Santiago Correa, PhD
Overview
Gender
- Male
Research
Dr. Correa develops biomaterials composed of nano-scale building blocks, which are used to reprogram the body’s immune system to fight cancer, autoimmune disease, and infection.
Taking inspiration from nature, Dr. Correa engineers this next-generation technology via supramolecular self-assembly across length scales – first by constructing bioinspired multifunctional nanoparticles that, in turn, self-assemble to produce macroscopic biomaterials imbued with unprecedented immuno-modulatory capabilities.
Dr. Correa obtained his BS in Biomedical Engineering at Yale prior to completing a PhD in Biological Engineering at MIT. While in the Hammond Lab at MIT, he explored how nanoparticle surface chemistry could be engineered to better target ovarian cancer and to fabricate multifunctional nanomaterials. Afterwards, Dr. Correa completed his postdoctoral training as an NCI F32 Fellow in the Appel Lab at Stanford, where he developed immunomodulatory biomaterials to treat cancer.